Condition

Cellulitis

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 9 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials9

Recruiting0

Common interventions12

Lead sponsors shown8

Clinical trials

9 shown

Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)NCT06526884 · 2024-07-22

COMPLETED

Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)NCT05473325 · 2023-01-01

UNKNOWN

Improving Safety of Diagnosis and Therapy in the Inpatient SettingNCT04393909 · 2019-07-01

COMPLETED

A Subjective Observational Study of Patients Using Medicated Footbath/Footwash Treatment in Podiatry CareNCT03781024 · 2018-12-01

UNKNOWN

Shock Waves for Treatment of Gynoid Lipodystrophy and Localized FatNCT03275259 · 2017-04-03

COMPLETED

Evaluation of Implementation of a National Point-of-Care Ultrasound Training ProgramNCT03296280 · 2016-10-03

COMPLETED

Hospitalization at Home: The Acute Care Home Hospital Program for AdultsNCT02864420 · 2016-09-01

COMPLETED

Feasibility and Outcomes of Older Patients HospitalizationNCT00489021 · 2007-07-01

UNKNOWN

Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic DispersionNCT01238276

NO_LONGER_AVAILABLE

Common interventions

CefazolinDRUG1 Diagnostic TimeoutBEHAVIORAL1 Diagnostic Uncertainty Educational CurriculumBEHAVIORAL1 Enhancements to Epic-integrated Quality & Safety DashboardBEHAVIORAL1 FootwashCOMBINATION_PRODUCT1 Home hospitalizationOTHER1 Inpatient HospitalizationOTHER1 Next Day ClinicOTHER1 Patient Diagnostic (Dx) QuestionnaireBEHAVIORAL1 Silberg Tissue Preparation SystemDEVICE1 sub-acute hospitalizationPROCEDURE1 THORK Shock Wave® (Extracorporeal shock waves)DEVICE1

Leading sponsors

Brigham and Women's Hospital 2 Data Collection Analysis Business Management 1 Hillel Yaffe Medical Center 1 Indústria Brasileira Equipamentos Médicos - IBRAMED 1 Sonescence, Inc. 1 University of California, Los Angeles 1 VA Office of Research and Development 1 Willows Health 1

Trial status mix

COMPLETED5

UNKNOWN3

NO_LONGER_AVAILABLE1

Phase mix

NA5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.